CONMED Corporation (CNMD)
NYSE · Healthcare
CONMED Corporation Shareholder Equity 2009–2025
CONMED Corporation annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- CONMED Corporation shareholder equity as of December 31, 2025: 1.03B, a 7.31% increase year-over-year.
- CONMED Corporation shareholder equity for 2025 were 1.03B, a 7.31% increase from 2024.
- CONMED Corporation shareholder equity for 2024 were 962.7M, a 15.40% increase from 2023.
- CONMED Corporation shareholder equity for 2023 were 834.2M, a 11.89% increase from 2022.
- CONMED Corporation shareholder equity for 2022 were 745.5M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| CONMED Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $1,033 |
| 2024 | $963 |
| 2023 | $834 |
| 2022 | $746 |
| 2021 | $785 |
| 2020 | $709 |
| 2019 | $710 |
| 2018 | $662 |
| 2017 | $631 |
| 2016 | $581 |
| 2015 | $585 |
| 2014 | $581 |
| 2013 | $606 |
| 2012 | $607 |
| 2011 | $573 |
CONMED Corporation Shareholder Equity — FAQ
CONMED Corporation (CNMD) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CNMD's shareholder equity history?
The chart and table above show CONMED Corporation's shareholder equity by year and by quarter, including the growth rate.